GALP
Galanin-like peptide
Also known as: GALP_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UBC7
- Gene
- GALP
- Ensembl
- ENSG00000197487
- Chromosome
- 19
- Canonical length
- 116 aa
- Protein class
- Predicted secreted proteins
- Secretome location
- Secreted in brain
OverviewNCBI Gene
This gene encodes a member of the galanin family of neuropeptides. The encoded protein binds galanin receptors 1, 2 and 3 with the highest affinity for galanin receptor 3 and has been implicated in biological processes involving the central nervous system including hypothalamic regulation of metabolism and reproduction. A peptide encoded by a splice variant of this gene, termed alarin, has vasoactive properties, displays antimicrobial activity against E. coli, and may serve as a marker for neuroblastic tumors.[provided by RefSeq, Nov 2014]
Canonical amino-acid sequenceUniProt
116 residues, UniProt reviewed canonical sequence.
>Q9UBC7|GALP
1 MAPPSVPLVL LLVLLLSLAE TPASAPAHRG RGGWTLNSAG YLLGPVLHLP QMGDQDGKRE
61 TALEILDLWK AIDGLPYSHP PQPSKRNVME TFAKPEIGDL GMLSMKIPKE EDVLKSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GALP can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.62
- Highest tissue expression
- 0.6 nTPM
Expression across tissuesHPA
Tissue
- liver: 0.6 nTPM
- amygdala: 0.2 nTPM
- basal ganglia: 0.2 nTPM
- hippocampal formation: 0.1 nTPM
- hypothalamus: 0.1 nTPM
- midbrain: 0.1 nTPM
Single-cell type
- retinal pigment epithelial cells: 4.3 nCPM
- parietal cells: 1.8 nCPM
- undifferentiated spermatogonia: 1.7 nCPM
- endometrial glandular cells: 1 nCPM
- thymocytes: 0.8 nCPM
- hepatocytes: 0.6 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- medulla oblongata: 0.7 nTPM
- amygdala: 0.6 nTPM
- cerebral cortex: 0.6 nTPM
- basal ganglia: 0.3 nTPM
- hypothalamus: 0.3 nTPM
- midbrain: 0.3 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.7
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.18
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- antimicrobial humoral immune response mediated by antimicrobial peptide
- behavioral response to starvation
- defense response to bacterium
- defense response to Gram-negative bacterium
- neuropeptide signaling pathway
- regulation of appetite
- response to insulin
- modulation of process of another organism
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GALP as an antibody target. Whether an autoantibody or antibody against GALP could matter depends on whether native GALP is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GALP is annotated as secreted, so native GALP circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label GALP as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...